Navigation Links
Jiuzhou Pharmaceutical to acquire API Manufacturing Facility in China

Zhejiang Jiuzhou Pharmaceutical Co., Ltd.“Jiuzhou Pharmaceutical, a world leading Active Pharmaceutical Ingredients (API) contract development and manufacturing organization (CDMO) today announced it has entered into a contractual commitment for the purchase of Suzhou Novartis Pharmaceutical Technology Ltd (SNPT), an API manufacturing facility in Changshu Economic Technology Development Zone, Suzhou, China.

Madam Lirong Hua, Chairman of the Board of Jiuzhou Pharmaceutical, commented, “By acquiring this manufacturing site in Suzhou, Jiuzhou Pharmaceutical can accelerate growth by adding new CDMO projects and develop new products for the market. It comes with an excellent manufacturing facility and a dedicated team of experts that will support us in delivering high-quality pharmaceuticals meeting or exceeding customer expectations and regulatory requirements.”

The SNPT site, is an established and reputable API manufacturing facility and provides a number of lifesaving medicines to patients around the world. As part of the agreement, the parties have committed to sign a long-term supply contract to guarantee continuous supply of products manufactured at SNPT. No impact on jobs is planned and Jiuzhou Pharmaceutical will invest in the site and pursue business development opportunities to optimize the utilization and expand the customer base.

“We look forward to a seamless transition for employees, patients, customers, partners and other stakeholders,” added Madam Hua. “We are impressed by the know-how at the SNPT plant and intend to leverage their expertise to develop new opportunities in the pharmaceutical market, in China and globally.”

The acquisition of the SNPT API manufacturing facility is subject to customary approval process of the competent authorities and will be completed by the end of 2019.

About Jiuzhou Pharmaceutical

Zhejiang Jiuzhou Pharmaceutical Co., Ltd, (Stock code 603456), was formed in 1998.
Jiuzhou Pharmaceutical is committed to the research & development, production, and sale of active pharmaceutical ingredients (APIs). In addition, the company offers one-stop CDMO services in Asia, Europe and North America through its Raybow Pharmaceutical division. Jiuzhou Pharmaceuticals has been honored with a number of industry and government accolades including “Top 100 in the Chinese Pharmaceutical Industry”, “National High-Tech Enterprise,“National Technology Innovation Demonstration Enterprises” and many other notable awards. The Company has a sterling track record with regulatory authorities including the FDA and EDQM and excellent compliance history of EHS. For more information on Jiuzhou, please visit our website.

Read the full story at

Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved

Related medicine technology :

1. Cumberland Pharmaceuticals To Present At The UBS Global Healthcare Conference In New York
2. Aoxing Pharmaceutical Company, Inc. Announces Financial Results For Third Quarter Of 2013 Fiscal Year
3. Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeants Board of Directors
4. DelMar Pharmaceuticals, Inc. Provides Corporate Update for the Quarter Ended March 31, 2013
5. Access Pharmaceuticals Reports First Quarter Results
6. The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals
7. Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference
8. AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
9. Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment
10. Aveo Pharmaceuticals, Inc. Sued by Investor
11. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm
Post Your Comments:
(Date:8/27/2020)... ... ... season is right round the corner and the risk of getting caught by influenza is ... begins to harbor its effects on us. Already with the sudden outbreak of COVID 19, ... lives. Hence it has become even more relevant to keep oneself immune from any of ...
(Date:8/27/2020)... ... August 27, 2020 , ... The GHT Companies , a leading ... for Feeding San Diego with a press conference at its manufacturing facility ... final check of $5,000.00+ representing an overall donation result exceeding $30,000 to Feeding San ...
(Date:8/26/2020)... (PRWEB) , ... August 26, 2020 , ... ... and in-home air purification systems kill Coronavirus. While air purification technologies, including GreenTech ... including SARS and even Ebola, no air purification system has published results of ...
Breaking Medicine Technology:
(Date:8/31/2020)... ... , ... Just found out your dear friend has cancer? , It’s hard to hear your ... shares their diagnosis. Once the shock wears off, the questions and fears can be overwhelming. ... best ways to help? Words are failing me. I’m scared. I want to DO something. ...
(Date:8/31/2020)... ... 31, 2020 , ... Colorado State University Global (CSU Global) ... online education – is proud to announce its new master’s degree in ... kind in the nation, the 60-credit hour program is designed to provide students ...
(Date:8/31/2020)... ... , ... In an effort to give back to the community in which ... hotel room booked with a special new rate code to benefit children and families ... immediately. Donations will be applied to any room type, any time, now through ...
(Date:8/28/2020)... ... August 28, 2020 , ... Ernst & ... was named an Entrepreneur Of The Year® 2020 Florida Award finalist. Now in ... whose ambitions deliver innovation, growth and prosperity as they build and sustain successful ...
(Date:8/28/2020)... ... ... Integrated Viral Protection (IVP Air) today announced that the True ... Mobile Biodefense Indoor Air Protection System that is the first system designed and proven ... equipped with the filtration system on September 8th. , The IVP Air S1 ...
Breaking Medicine News(10 mins):